Monthly Cost Analysis: Wegovy vs Mounjaro Pricing Structure
Is Wegovy Better Than Mounjaro for Long-Term Budgeting?
When evaluating whether Wegovy or Mounjaro is more suitable, the monthly cost structure plays a crucial role in treatment sustainability. Wegovy follows a 16-week dose escalation protocol, with monthly costs starting at £79.99 for the initial 0.25mg dose and gradually increasing to £209.99 for the maintenance 2.4mg dose. This predictable escalation allows patients to budget effectively for their weight management journey. Mounjaro follows a similar escalation pattern but uses different dose increments and pricing tiers.
The key advantage of Wegovy's pricing structure is its transparency and the availability of bundle options that can help manage costs over multiple months. EverydayMeds offers Getting Started bundles like the Intro Duo (0.25mg & 0.5mg) for £169.99, covering the first two months of treatment. For long-term treatment, the Ultimate Stability Trio provides three months of maintenance doses for £649.99, ensuring consistent supply without monthly reordering.
Wegovy Pricing Breakdown: Complete Monthly Cost Analysis
The complete Wegovy cost journey begins with the starter dose at £79.99 monthly (weeks 1-4), progressing to £94.99 for the 0.5mg dose (weeks 5-8), then £99.99 for 1mg (weeks 9-12), and £139.99 for 1.7mg (weeks 13-16). The maintenance dose of 2.4mg costs £209.99 monthly from week 17 onwards. These prices include the FIRST40 discount for new customers and DOSE25 for returning patients, applied automatically at checkout. Annual maintenance cost at the 2.4mg dose totals approximately £2,519.88, making it competitive within the UK weight management market.
Bundle pricing provides additional convenience without compromising value. The Progress Trio (0.5mg, 1mg & 1.7mg) costs £369.99, covering months 2-4 of treatment in a single order. Consistency bundles offer two identical doses for patients requiring extended time at specific dose levels, such as the Consistency 1mg bundle at £209.99. All pricing reflects final costs after discount codes, ensuring transparency in treatment budgeting.
Clinical Evidence: Is Wegovy Better Than Mounjaro Based on Trial Data?
Wegovy's clinical efficacy is demonstrated through the comprehensive STEP trial programme. In STEP 1, patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, adding significant clinical value beyond weight management.
Comparing Wegovy and Mounjaro trial results directly isn't appropriate due to different study designs, populations, and endpoints. Both treatments have demonstrated efficacy in their respective clinical programmes, with Wegovy's data spanning over two years of continuous use in STEP 5. The choice between treatments should be based on individual patient factors, tolerability, and prescriber guidance rather than head-to-head trial comparisons.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation and glucose control. When injected once weekly, it slows gastric emptying, promoting feelings of fullness after smaller meals and reducing overall caloric intake. The medication works on brain appetite centres, potentially reducing food cravings and the psychological drive to eat. Unlike Mounjaro's dual GIP/GLP-1 mechanism, Wegovy focuses specifically on GLP-1 pathways, providing a well-understood and extensively studied approach to weight management. This targeted mechanism has been refined through years of clinical development, resulting in the current maintenance dose of 2.4mg weekly.
Ordering Process: Getting Your Wegovy Prescription
EverydayMeds streamlines the Wegovy ordering process through a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Following submission, qualified prescribers review applications within 3 working days (24-hour express review available), ensuring appropriate clinical oversight for this prescription-only medicine. Once approved, orders are dispatched via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. The process includes automatic dose escalation reminders and clinical check-ins to support treatment continuity. All services operate under GPhC registration #9012878, ensuring full regulatory compliance and patient safety throughout the treatment journey.
Storage and Practical Considerations: Wegovy vs Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable for up to 6 weeks at room temperature below 30°C once removed from the fridge. Mounjaro requires refrigeration return within 21 days, making Wegovy more convenient for travel and daily use. The FlexTouch pen delivery system provides accurate dosing with a simple injection process suitable for self-administration. Unused Wegovy should be stored at 2-8°C, and the mandatory dose escalation protocol cannot be accelerated, ensuring optimal tolerability. Each pen contains exactly four weeks of treatment, with clear dose markings and an easy-to-read display. The 16-week escalation to maintenance dosing allows the body to adapt gradually, minimising potential side effects while maximising therapeutic benefits.
Is Wegovy Better Than Mounjaro for UK Patients' Monthly Budgeting?
For UK patients concerned about ongoing treatment costs, Wegovy's transparent pricing structure offers predictable monthly expenses throughout the treatment journey. The escalation phase spans exactly 16 weeks with known costs at each stage, followed by consistent maintenance pricing at £209.99 monthly. EverydayMeds' bundle options provide cost-effective alternatives for patients preferring quarterly ordering rather than monthly purchases.
The DOSE25 returning customer discount ensures long-term patients maintain competitive pricing throughout their treatment. Combined with Wegovy's proven storage stability and convenient weekly injection schedule, the total cost of ownership remains competitive within the UK weight management market. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your clinical needs and budget considerations.
Starting Your Treatment: Discount Codes and Final Costs
New EverydayMeds customers benefit from the FIRST40 discount code, bringing the initial 0.25mg Wegovy dose to £79.99, while returning customers use DOSE25 for continued savings. These codes apply automatically at checkout, ensuring the advertised prices reflect your final payment without hidden fees or additional charges. The clinical assessment fee is included in the treatment cost, providing comprehensive prescriber review and ongoing clinical support. Orders include next-day delivery and temperature monitoring to ensure medication quality from pharmacy to patient. EverydayMeds operates as a fully registered UK pharmacy (GPhC #9012878), providing legitimate access to this prescription-only medicine with complete regulatory compliance and professional clinical oversight.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
